Patents by Inventor Homer F. WILLIS

Homer F. WILLIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170306417
    Abstract: The present disclosure includes methods for the prediction of outcome in breast cancer where EGFR/ErbB family members are over expressed and the benefit of treatment with an anti-ErbB antibody. More specifically, the present invention relates the use of the mRNA expression level of a C8A, OR56A1, or PRR20C biomarker compared to a reference expression level for providing information regarding the benefit of treatment with a HER2 antibody, such as trastuzumab, in HER2+ breast cancer.
    Type: Application
    Filed: November 12, 2015
    Publication date: October 26, 2017
    Inventors: Brian LEYLAND-JONES, Homer F. WILLIS